anmelden
FTSE 100
10.233,07
PKT
-43,88
PKT
-0,43
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu FTSE 100-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 27.10.22 | Unilever Sell | UBS AG | |
| 27.10.22 | Barclays Outperform | Credit Suisse Group | |
| 27.10.22 | Unilever Equal Weight | Barclays Capital | |
| 27.10.22 | AstraZeneca Overweight | Barclays Capital | |
| 27.10.22 | Lloyds Banking Group Buy | Goldman Sachs Group Inc. | |
| 27.10.22 | Unilever Outperform | Bernstein Research | |
| 27.10.22 | GSK Neutral | JP Morgan Chase & Co. | |
| 27.10.22 | GSK Neutral | JP Morgan Chase & Co. | |
| 27.10.22 | Unilever Neutral | Goldman Sachs Group Inc. | |
| 27.10.22 | Barclays Buy | Goldman Sachs Group Inc. | |
| 27.10.22 | Barclays Hold | Deutsche Bank AG | |
| 27.10.22 | HSBC Hold | Deutsche Bank AG | |
| 27.10.22 | Standard Chartered Buy | Deutsche Bank AG | |
| 27.10.22 | Unilever Underweight | JP Morgan Chase & Co. | |
| 27.10.22 | Barclays Sector Perform | RBC Capital Markets | |
| 26.10.22 | HSBC Neutral | JP Morgan Chase & Co. | |
| 26.10.22 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 26.10.22 | Barclays Buy | Jefferies & Company Inc. | |
| 26.10.22 | HSBC Neutral | Credit Suisse Group | |
| 26.10.22 | HSBC Overweight | Barclays Capital | |
| 26.10.22 | Standard Chartered Buy | UBS AG | |
| 26.10.22 | Barclays Buy | UBS AG | |
| 26.10.22 | HSBC Hold | Deutsche Bank AG | |
| 26.10.22 | Barclays Neutral | JP Morgan Chase & Co. | |
| 25.10.22 | HSBC Neutral | Goldman Sachs Group Inc. | |
| 25.10.22 | GSK Hold | Deutsche Bank AG | |
| 25.10.22 | HSBC Outperform | RBC Capital Markets | |
| 25.10.22 | HSBC Buy | UBS AG | |
| 25.10.22 | HSBC Neutral | JP Morgan Chase & Co. | |
| 25.10.22 | HSBC Hold | Jefferies & Company Inc. | |
| 24.10.22 | Diageo Overweight | Barclays Capital | |
| 24.10.22 | Unilever Sell | UBS AG | |
| 24.10.22 | easyJet Hold | Deutsche Bank AG | |
| 24.10.22 | GSK Equal Weight | Barclays Capital | |
| 24.10.22 | GSK Neutral | JP Morgan Chase & Co. | |
| 22.10.22 | RELX Buy | Goldman Sachs Group Inc. | |
| 21.10.22 | RELX Overweight | JP Morgan Chase & Co. | |
| 21.10.22 | RELX Outperform | Credit Suisse Group | |
| 21.10.22 | AstraZeneca Neutral | Credit Suisse Group | |
| 21.10.22 | RELX Buy | UBS AG |
* Die angezeigten Realtime Kurse sind indikativ und nicht die offiziellen Börsenkurse. Die Kursdaten können eventuell vom tatsächlichen Marktpreis abweichen.